FDA Approves Oral Contraceptive, Cervical Cancer Detection Device
Tue, 21 Mar 2006 02:00 AM EST
... FDA on Friday announced that it has approved Schering''s oral contraceptive pill YAZ, a low-dose version of Schering''s FDA-approved contraceptive pill Yasmin, Reuters reports (Reuters, 3/17). YAZ, which is manufactured by the Schering subsidiary Berlex, contains ethinyl estradiol and drospirenone and is taken once a day for 24 days followed by four days of placebo to induce a menstrual period... click link for more info. ...
Related Topics
- Cervical Cancer
- Oral Cancer
- Neck Disorders and Injuries
- Testicular Cancer
- Drug and Medical Device Safety
- Iud
- Cervical Dysplasia
- Tacrolimus ointment
- Cancers
- Iud / Intrauterine Device
- Uterine Cancer
- Pimecrolimus Cream 1%
- Cervical Stenosis
- Carcinogens
- Cancer
- Thalidomide
- Clinical Trials
- Cancer Radiation Therapy
- Prostate Cancer
- Cancer, Cervical

Not Signed In -


